| Home | E-Submission | Sitemap | Contact Us |  
Korean Journal of Clinical Oncology > Article
Kim and Kang: Pancreatoduodenectomy with colon-last approach for advanced pancreatic head cancer

ABSTRACT

Purpose

Margin-negative surgery is very important in surgical oncology. Considering margin-negative pancreatectomy is known to be essential for cure of the pancreatic cancer, pancreatoduodenectomy with combined venous vascular or arterial resection can be a potential option for margin-negative resection, especially, in era of neoadjuvant treatment with potent systemic chemotherapy. To the contrary, special attention was not paid on combined colonic resection during PD. In this article, safe surgical technique for PD with combined colonic resection is introduced, under the name of PD with “colon-last” approach.

Methods

At Severance Hospital (Yonsei University College of Medicine, Seoul, Republic of Korea), between 2014 and 2021, a total of six patients underwent PD with “colon-last” approach. The surgical technique and surgical outcome are reviewed.

Results

All patients recovered without major complications (Clavien-Dindo classification grade ≥III) after surgery, and most of them recovered after conservative treatment with postoperative pancreatic fistula biochemical leak. None of the patients were readmitted. Only the first and second cases represent cancer-related mortality, and the other patients are still alive and are being followed up.

Conclusion

It is hoped that the present technique, PD with colon-last approach, could be helpful enhance the procedural safety in treating advanced cancer requiring PD with combined colon resection. However, its technical safety and oncologic role should be validated by many pancreatic surgeons’ collaborative studies in the near future.

INTRODUCTION

Margin-negative surgery is very important in surgical oncology. Adjacent organs often need to be simultaneously removed due to anatomical intimacy with primary tumor. In spite of raising concerns about quality of life and patient’ safety, combined multi-organ resection should be decided in well selected patients for radical surgery.
Pancreatoduodenectomy (PD) itself is thought be one of the surgical procedures composed of multiple organ resection (pancreatic head, distal bile duct, and duodenum, or even distal part of stomach) for complete removal of malignant disease in periampullary lesion. Considering margin-negative pancreatectomy is known to be essential for cure of the pancreatic cancer, PD with combined venous vascular or arterial resection can be a potential option for margin-negative resection [13], especially, in era of neoadjuvant treatment with potent systemic chemotherapy [3,4].
To the contrary, special attention was not paid on combined colonic resection during PD. Most literatures seemed that PD was the additional approach for treating advanced right colon cancer [5,6]. However, there is still controversy in the safety of combined colonic resection in PD [79]. Recent systemic review showed en bloc PD with right hemicolectomy is rarely performed, but it can be a potentially safe treatment option in patients with locally advanced right colon cancer [5]. However, Solaini et al. [10] concluded PD-colon for pancreatic ductal adenocarcinoma seems to be associated with an increased morbidity and mortality but with survival comparable with standard PD in selected patients.
In our early experiences, once, there was a patient with pancreatic cancer who should have received PD with combined colonic resection for margin-negative resection. At that time, surgical dissection of uncinated process from superior mesenteric artery (SMA) was the last step for en block resection as usual. However, the patient had to experience profound gram-negative sepsis during the whole surgical procedure because colonic segment resected with en block “PD-last” approach resulted in vascular compromising of resected colon, which was thought to be septic nidus (Fig. 1A). In addition, severe adhesion and inflammatory changes around the pancreas and bile duct led to prolonged operation time to complete surgical procedure.
In this article, safe surgical technique for PD with combined colonic resection is introduced, under the name of PD with “colon-last” approach. Personal experiences and potential advantages of this surgical technique are also discussed. This surgical procedure is rarely performed, but it is hoped that PD with colon-last approach could provide the patients with good quality of radical surgery, and patients’ safety, as well.

METHODS

Surgical technique-video

The patient’s condition before surgery needs to be reviewed from various angles. This surgery should exclude cases where distant metastasis is difficult to obtain the oncologic benefit of margin-negative resection. It is necessary to review the direction of tumor growth based on computed tomography (CT) taken before surgery. A “colon-last” approach can be considered if the vector from which the tumor grows is directed towards the antero-inferior (colon mesentery). Before surgery, it is necessary to check the patient’s history of colon surgery. In patients who previously had inferior mesenteric artery high ligation through the anterior resection of colon, if the transverse colon is supplied with blood only through the middle colic artery, ischemic changes may occur in the remnant colon during this operation. To review this, it may be helpful to check the bloody supply of the colon by performing an abdomen angio-CT before surgery. Written informed consent was obtained from all patients.

Surgical approach

First, the patient is placed in supine position. Selective staging laparoscopy is performed during the same procedure, to rule out peritoneal seeding and occult metastasis. If no metastases are found, it is converted to open surgery. In this case, inverted L incision is preferred to ensure visibility. After confirming the location of the tumor, it is checked whether the vector in which the tumor grows is consistent with the preoperative imaging findings and whether segmental resection of the colon is absolutely necessary. In most cases, combined partial excision of colonic mesentery can preserve colon (e.g., by mesenteric approach [11]), however, in certain cases where extent of tumor invasion approaches near the mesenteric border of the colon or even is directly into the colon, PD with “colon-last” approach could be considered.
Standard PD performed as usual. When combined colonic resection is decided to be performed, main trunk of middle colic artery is isolated and preserved. It can be ligated according to the extent of colonic resection, but mostly it can be preserved because tumor invading portion is not that extensive in resectable pancreatic cancer. But its branch to the resected portion of the colon need to be controlled and distal part of the colon is divided by GIA stapler. This procedure can facilitate subsequent surgical dissection of uncinated process from the SMA. Right colic artery is divided with ileocolic artery is preserved (this part can be also conserved according to extent of the tumor invasion), so that the remaining colon is supplied with blood by the ileocolic artery (Fig. 1B). As shown in Fig. 1B, a viable colon color can still be maintained by the ileocolic artery unit. After completely separating retroperitoneal margin from SMA, division of the pancreatic neck and bile duct, finally, the colon was cut by securing sufficient margin in the proximal portion of the colon invaded by the tumor.
In this fashion, the pancreatic head and tumor are excised with en bloc while attached to the colon. Colon reconstruction, PD, hepaticojejunostomy, duodenojejunostomy are performed as usual [12,13]. The abdomen is closed and a surgical drain is left around the reconstruction site.

RESULTS

At Severance Hospital (Yonsei University College of Medicine, Seoul, Republic of Korea), between 2014 and 2021, a total of six patients underwent PD with “colon-last” approach. Their average age was 64.83 years, and there were many relatively elderly patients. The male to female ratio was 2:1, twice as many men as women. Half of the patients underwent surgery for pancreatic cancer, and each had stomach cancer, gallbladder cancer, and colon cancer. One of them received neoadjuvant chemotherapy for pancreatic cancer, and one received neoadjuvant chemotherapy for colon cancer. Fifty percent of patients suspected superior mesenteric vein (SMV) invasion during surgery, and SMV segmental resection was performed. The average operation time was 582.17 minutes, and the amount of blood loss during surgery was 825 cc. Three patients with more than 1,000 cc of intraoperative bleeding received blood transfusions during surgery. All patients recovered without major complications (Clavien-Dindo classification grade ≥ III [14]) after surgery, and most of them recovered after conservative treatment with postoperative pancreatic fistula biochemical leak. None of the patients were readmitted. Only the first and second cases represent cancer-related mortality, and the other patients are still alive and are being followed up.
In case 4, the gallbladder was perforated due to gallbladder cancer. Curative intent surgery was performed because peritoneal seeding was thought to be localized, covered by omentum, colon, and duodenum according to both preoperative CT scan and intraoperative finding. Since the peritoneal seeding was limited around the tumor, we decided that en bloc resection by PD with colon-last approach would be helpful for the patient’s prognosis. This patient underwent PD with colon-last approach (right hemicolectomy) followed by hyperthermic intraperitoneal chemotherapy. Currently, this patient has been alive for more than 1 year and is under follow-up (Table 1).

DISCUSSION

According to personal experiences, there are several advantages of PD with colon-last approach; First, by avoiding surgical separation between colonic mesentery and pancreatic head, intact margin-negative anterior aspect of the pancreatic head portion can be obtained. Second, as results, it also can reduce the chance of potential tumor spillage by omitting dissection colonic mesentery from pancreatic head portion. Third, by dividing transverse colon first, good surgical field can be obtained for appropriate dissection toward SMV and SMA. In other words, mesenteric approach [11,15,16] and anterior approach [17] are thought to be much easier, resulting in facilitating safe combined venous vascular resection and clear SMA lateral margin as shown in the video (Supplementary Video 1). In addition, even combined en bloc venous vascular resection can be ensured. Fourth, colonic perfusion can be conserved to the end of the surgical procedure. In spite of long operation time for PD, well preserved ileocolic artery and responsible collaterals (in spite of controlling right colic artery) guarantee the good colonic perfusion to avoid unexpected intraoperative gram-negative septic event. Lastly, according to the condition of colon perfusion, ileocecal value can be also preserved for future quality of the patient’s life.
Marsman et al. [18] recently performed a nationwide retrospective analysis on PD with colonic resection for cancer patients. From 2004 to 2014, 13 centers of the Dutch pancreatic cancer group reviewed the surgical outcome of PD with colonic resection for periampullary or colon cancer. Only 1.6% of the patients (50 out of 3,218 patients) underwent PD with colonic resection, and showed 90-day severe complication (Clavien-Dindo classification grade ≥ III) occurred in 60% of the patients with 6% surgery-related mortality. They concluded that PD with colonic resection was associated with considerable complications, but could ensure acceptable survival rates as long as tumor negative resection margin was achieved. However, as noted in previous meta-analysis [10], the study period is very old. Considering recent advance of surgical technique based on the accumulating experiences, concerns regarding the procedural safety is still open to be answered. Especially, in era of new potent chemotherapeutic agents, surgical safety should be mandatory for ensuring long-term survival of cancer patients.
It is hoped that the present technique, PD with colon-last approach, could be helpful enhance the procedural safety in treating advanced cancer requiring PD with combined colon resection. However, its technical safety and oncologic role should be validated by many pancreatic surgeons’ collaborative studies in near future.

ACKNOWLEDGEMENTS

The authors thank Medical Illustration & Design, part of the Medical Research Support Services of Yonsei University College of Medicine, for all artistic support related to this work.

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

Notes

FUNDING
None.

SUPPLEMENTARY MATERIALS

Supplementary materials are available at the Korean Journal of Clinical Oncology website (http://www.kjco.org/).

REFERENCES

1. Park H, Kang I, Kang CM. Laparoscopic pancreaticoduodenectomy with segmental resection of superior mesenteric vein-splenic vein-portal vein confluence in pancreatic head cancer: can it be a standard procedure? Ann Hepatobiliary Pancreat Surg 2018;22:419-24.
crossref pmid pmc
2. Gong Y, Zhang L, He T, Ding J, Zhang H, Chen G, et al. Pancreaticoduodenectomy combined with vascular resection and reconstruction for patients with locally advanced pancreatic cancer: a multicenter, retrospective analysis. PLoS One 2013;8:e70340.
crossref pmid pmc
3. Delpero JR, Sauvanet A. Vascular resection for pancreatic cancer: 2019 French recommendations based on a literature review from 2008 to 6-2019. Front Oncol 2020;10:40.
crossref pmid pmc
4. Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, et al. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. Surgery 2019;166:277-85.
crossref pmid
5. Khalili M, Daniels L, Gleeson EM, Grandhi N, Thandoni A, Burg F, et al. Pancreaticoduodenectomy outcomes for locally advanced right colon cancers: a systematic review. Surgery 2019;166:223-9.
crossref pmid
6. Kaneda Y, Noda H, Endo Y, Kakizawa N, Ichida K, Watanabe F, et al. En bloc pancreaticoduodenectomy and right hemicolectomy for locally advanced right-sided colon cancer. World J Gastrointest Oncol 2017;9:372-8.
crossref pmid pmc
7. Zhang J, Leng JH, Qian HG, Qiu H, Wu JH, Liu BN, et al. En bloc pancreaticoduodenectomy and right colectomy in the treatment of locally advanced colon cancer. Dis Colon Rectum 2013;56:874-80.
crossref pmid
8. Cirocchi R, Partelli S, Castellani E, Renzi C, Parisi A, Noya G, et al. Right hemicolectomy plus pancreaticoduodenectomy vs partial duodenectomy in treatment of locally advanced right colon cancer invading pancreas and/or only duodenum. Surg Oncol 2014;23:92-8.
crossref pmid
9. Paquette IM, Swenson BR, Kwaan MR, Mellgren AF, Madoff RD. Thirty-day outcomes in patients treated with en bloc colectomy and pancreatectomy for locally advanced carcinoma of the colon. J Gastrointest Surg 2012;16:581-6.
crossref
10. Solaini L, de Rooij T, Marsman EM, Te Riele WW, Tanis PJ, van Gulik TM, et al. Pancreatoduodenectomy with colon resection for pancreatic cancer: a systematic review. HPB (Oxford) 2018;20:881-7.
crossref pmid
11. Nakao A. The mesenteric approach in pancreatoduodenectomy. Dig Surg 2016;33:308-13.
crossref pmid
12. Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR. Personal experience of pancreas reconstruction following pancreaticoduodenectomy. ANZ J Surg 2006;76:339-42.
crossref pmid
13. Navarro JG, Kang CM. Pitfalls for laparoscopic pancreaticoduodenectomy: need for a stepwise approach. Ann Gastroenterol Surg 2019;3:254-68.
crossref pmid pmc
14. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.
pmid pmc
15. Nakao A, Takagi H. Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepatogastroenterology 1993;40:426-9.
pmid
16. Zhu J, Han D, Li X, Pan F, Ma J, Kou J, et al. Inferior infracolic ‘superior mesenteric artery first’ approach with a no-touch isolation surgical technique in patients with a borderline resectable cancer of the pancreatic head. Ann Surg Oncol 2016;23:976-80.
crossref pmid
17. Inoue Y, Saiura A, Yoshioka R, Ono Y, Takahashi M, Arita J, et al. Pancreatoduodenectomy with systematic mesopancreas dissection using a supracolic anterior artery-first approach. Ann Surg 2015;262:1092-101.
crossref pmid
18. Marsman EM, de Rooij T, van Eijck CH, Boerma D, Bonsing BA, van Dam RM, et al. Pancreatoduodenectomy with colon resection for cancer: a nationwide retrospective analysis. Surgery 2016;160:145-52.
crossref pmid

Fig. 1
(A) Pancreatoduodenectomy-last approach, resected colon with ischemic change. (B) Colon-last approach. P, pancreas; T, tumor; C, colon; a-a’, middle colic artery; b-b’, right colic artery.
kjco-20-1-13f1.jpg
Table 1
Perioperative characteristics of all patients
No. Age (yr)/Sex Diagnosis Neoadjuvant Tx Operation date Operation name Venous resection ICV-preserving Operation time (min) Intraoperative blood loss (mL) Transfusion (mL) Complication Re-admission Follow-up (mo), (status)
1 74/M Pancreatic cancer No 2014-11-25 PD with colon SR No Yes 508 400 0 POPF BL No 30 (death)
2 58/M Stomach cancer No 2016-03-23 PD with colon SR SMV/PV SR Yes 719 1,300 537 POPF BL No 38 (death)
3 58/F Pancreatic cancer Yes 2019-11-06 PD with colon SR SMV SR Yes 394 350 0 POPF BL No 19 (alive)
4 72/M Gallbladder cancer No 2020-05-12 PD with RHC, HIPEC No No 666 1,100 300 POPF BL No 12 (alive)
5 62/M Colon cancer Yes 2020-06-15 PD with RHC No No 670 1,400 500 DGE, ileus No 11 (alive)
6 65/F Pancreatic cancer No 2021-01-26 PD with colon SR SMV SR Yes 536 400 0 No No 4 (alive)

Tx, treatment; ICV, ileocolic vessel; PD, pancreatoduodenectomy; SR, segmental resection; POPF BL, postoperative pancreatic fistula biochemical leak; SMV, superior mesenteric vein; PV, portal vein; RHC, right hemi-colectomy; HIPEC, hyperthermic intraperitoneal chemotherapy; DGE, delayed gastric emptying.

Editorial Office
101-3304 Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea
TEL : +82-2-393-2114   FAX : +82-2-393-1649   E-mail : office@kjco.org

Copyright© Korean Society of Surgical Oncology.                Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers